Postgrad Med J 2001;77:24 ( January )

Review

Posterior leukoencephalopathy syndrome R K Garg

Department of Neurology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India

Correspondence to: Dr Ravindra K Garg, Department of Neurology, KG's Medical College, Lucknow 226 003, India garg50{at}Yahoo.com

Submitted 20 September 1999; Accepted 19 April 2000

Posterior leukoencephalopathy syndrome is a newly recognised brain disorder that predominantly affects the cerebral white matter. Oedematous lesions particularly involve the posterior parietal and occipital lobes, and may spread to basal ganglia, brain stem, and cerebellum. This rapidly evolving neurological condition is clinically characterised by headache, nausea and vomiting, seizures, visual disturbances, altered sensorium, and occasionally focal neurological deficit. Posterior leukoencephalopathy syndrome is often associated with an abrupt increase in blood pressure and is usually seen in patients with eclampsia, renal disease, and hypertensive encephalopathy. It is also seen in the patients treated with cytotoxic and immunosuppressive drugs such as cyclosporin, tacrolimus, and interferon alfa. The lesions of posterior leukoencephalopathy are best visualised with magnetic resonance (MR) imaging. T2 weighted MR images, at the height of symptoms, characteristically show diffuse hyperintensity selectively involving the parieto-occipital white matter. Occasionally the lesions also involve the grey matter. Computed tomography can also be used satisfactorily to detect hypodense lesions of posterior leukoencephalopathy. Early recognition of this condition is of paramount importance because prompt control of blood pressure or withdrawal of immunosuppressive agents will cause reversal of the syndrome. Delay in the diagnosis and treatment can result in permanent damage to affected brain tissues.


Keywords: leukoencephalopathy; eclampsia; hypertensive encephalopathy; occipital lobe seizures

---

© 2001 by The Fellowship of Postgraduate Medicine
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hefzy, H.M., Bartynski, W.S., Boardman, J.F., Lacomis, D. (2009). Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features. Am. J. Neuroradiol. 30: 1371-1379 [Abstract] [Full Text]  
• Bartynski, W.S. (2008). Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features. Am. J. Neuroradiol. 29: 1036-1042 [Abstract] [Full Text]  
• El Karoui, K., Le Quintrec, M., Dekeyser, E., Servais, A., Hummel, A., Fadel, F., Fakhouri, F. (2008). Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. Nephrol Dial Transplant 23: 757-763 [Full Text]  
• Kapiteijn, E., Brand, A., Kroep, J., Gelderblom, H. (2007). Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome. Ann Oncol 18: 1745-1747 [Full Text]  
• Nagel, S., Kohrmann, M., Huttner, H. B., Storch-Hagenlocher, B., Schwab, S. (2007). Linezolid-Induced Posterior Reversible Leukoencephalopathy Syndrome. Arch Neurol 64: 746-748 [Abstract] [Full Text]  
• Alehan, F., Erol, I., Agildere, A. M., Ozcay, F., Baskin, E., Cengiz, N., Alioglu, B., Haberal, M. (2007). Posterior Leukoencephalopathy Syndrome in Children and Adolescents. J Child Neurol 22: 406-413 [Abstract]  
• Al-Ansari, M., Todwal, A. (2007). A 20-Year-Old Man With Status Epilepticus and Uncontrolled Hypertension. Chest 131: 309-312 [Full Text]  
• Allen, J. A., Adlakha, A., Bergethon, P. R. (2006). Reversible Posterior Leukoencephalopathy Syndrome After Bevacizumab/FOLFIRI Regimen for Metastatic Colon Cancer.. Arch Neurol 63: 1475-1478 [Abstract] [Full Text]  
• Heiss, S., Krampla, W., Klauser-Braun, R. (2006). A patient recently transplanted with a living donor kidney develops severe neurological symptoms. Nephrol Dial Transplant 21: 2017-2019 [Full Text]  
• Glusker, P., Recht, L., Lane, B., Ozcan, C., Wong, S. J., Hari, P., Barron, H. (2006). Reversible posterior leukoencephalopathy syndrome and bevacizumab.. NEJM 354: 980-982 [Full Text]  
• Mehall, J. R., Leach, J. L., Merrill, W. H. (2005). Posterior reversible encephalopathy syndrome after nontransplant cardiac surgery. J. Thorac. Cardiovasc. Surg. 130: 1473-1474 [Full Text]  
• Brown, C. A., Munday, J. S., Mathur, S., Brown, S. A. (2005). Hypertensive Encephalopathy in Cats with Reduced Renal Function. Vet Pathol 42: 642-649 [Abstract] [Full Text]  
• Yong, P. F. K., Hamour, S. M. A., Burns, A. (2003). Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome. Nephrol Dial Transplant 18: 2660-2662 [Full Text]  
• Bakker, R. C., Verburgh, C. A., van Buchem, M. A., Paul, L. C. (2003). Hypertension, cerebral oedema and fundoscopy. Nephrol Dial Transplant 18: 2424-2427 [Full Text]  
• Finsterer, J., Schlager, T., Kopsa, W., Wild, E. (2003). Nitroglycerin-aggravated pre-eclamptic posterior reversible encephalopathy syndrome (PRES). Neurology 61: 715-716 [Full Text]  
• BANERJEE, A K (2001). Posterior leukoencephalopathy syndrome. Postgrad. Med. J. 77: 551-551 [Full Text]